Home  /  Resource Library  /  Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison

Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison

Results of a study comparing the efficacy of CAR T therapy Tisagenlecleucel with CAR T lisocabtagene maraleucel for treatment of relapsed large cell lymphomas.